genoset-123
Determines if a genome has an increased risk of basal cell carcinoma as per gs123.
Determines if a genome has an increased risk of basal cell carcinoma as per gs123.
Determines if a genome has an increased risk of basal cell carcinoma as per gs126.
Of the 'poor metabolizer' phenotype for CYP2C19.
A JavaScript client for communicating with the 23andMe API.
You have a 1.7x increased risk for panic disorder
You have at least 4 of the 5 genotypes which increase, by approximately 50%, the risk of prostate cancer patients dying of the disease. This does not increase your risk of getting prostate cancer, however.
You have a lower risk for developing Parkinson's Disease
You are at an increased risk for developing Parkinson's Disease
Most likely CYP2C19 normal, i.e. CYP2C19*1, and therefore of the 'rapid metabolizer' phenotype.
Your CYP1A2 fast metabolizer status means that you are less stimulated by caffeine.